Referenced Citations Ahrn, B., et al., Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
Remember that individual results may vary, and open communication with healthcare providers remains crucial in optimizing the long-term benefits of GLP-1 analogue therapies
The Role of Professional Support in Long-Term Success Weight regain after GLP-1 discontinuation is significantly reduced when you maintain regular contact with a healthcare provider or registered dietitian, even if it's just quarterly check-ins
As a result, many patients explore alternative access options such as cash-pay programs and telehealth-based prescribing
Though emerging evidence suggests GLP-1 RA use may be beneficial for improving psoriatic disease activity, metabolic outcomes, and systemic inflammation, most research was conducted through prospective studies, small trials, or cohort analyses